Nicholas Joseph Swerdlow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endovascular Procedures | 35 | 2024 | 2258 | 3.120 |
Why?
|
Aortic Aneurysm, Abdominal | 26 | 2024 | 1252 | 3.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 25 | 2024 | 1460 | 2.710 |
Why?
|
Blood Vessel Prosthesis | 14 | 2024 | 959 | 1.480 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2024 | 709 | 1.050 |
Why?
|
Stents | 13 | 2024 | 3204 | 1.040 |
Why?
|
Endoleak | 5 | 2022 | 111 | 1.010 |
Why?
|
Prosthesis Design | 9 | 2024 | 2126 | 0.750 |
Why?
|
Vascular Surgical Procedures | 6 | 2020 | 1509 | 0.730 |
Why?
|
Postoperative Complications | 21 | 2024 | 15880 | 0.690 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2019 | 93 | 0.640 |
Why?
|
Carotid Artery Diseases | 3 | 2020 | 879 | 0.600 |
Why?
|
Carotid Stenosis | 6 | 2020 | 864 | 0.600 |
Why?
|
Aortography | 2 | 2023 | 422 | 0.590 |
Why?
|
Aortic Aneurysm | 2 | 2020 | 649 | 0.570 |
Why?
|
Vascular Grafting | 1 | 2019 | 163 | 0.560 |
Why?
|
Endarterectomy, Carotid | 5 | 2020 | 558 | 0.560 |
Why?
|
Aortic Rupture | 4 | 2021 | 322 | 0.550 |
Why?
|
Radiography, Interventional | 2 | 2018 | 1127 | 0.460 |
Why?
|
Femoral Artery | 4 | 2020 | 829 | 0.400 |
Why?
|
Time Factors | 30 | 2024 | 40271 | 0.390 |
Why?
|
Catheterization, Peripheral | 3 | 2020 | 346 | 0.390 |
Why?
|
Treatment Outcome | 39 | 2024 | 65409 | 0.360 |
Why?
|
Risk Assessment | 23 | 2024 | 24311 | 0.330 |
Why?
|
Risk Factors | 35 | 2024 | 74915 | 0.320 |
Why?
|
Aged, 80 and over | 30 | 2024 | 59680 | 0.310 |
Why?
|
Stroke | 9 | 2023 | 9791 | 0.300 |
Why?
|
Aorta, Abdominal | 3 | 2020 | 627 | 0.300 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4077 | 0.300 |
Why?
|
Retrospective Studies | 38 | 2024 | 81834 | 0.300 |
Why?
|
Databases, Factual | 13 | 2021 | 8081 | 0.270 |
Why?
|
Eligibility Determination | 2 | 2021 | 420 | 0.260 |
Why?
|
Aged | 41 | 2024 | 171520 | 0.240 |
Why?
|
Registries | 11 | 2021 | 8373 | 0.230 |
Why?
|
Aortic Diseases | 2 | 2021 | 742 | 0.230 |
Why?
|
Aorta, Thoracic | 2 | 2021 | 1107 | 0.220 |
Why?
|
Spinal Cord Ischemia | 1 | 2023 | 94 | 0.200 |
Why?
|
Fluoroscopy | 3 | 2023 | 952 | 0.180 |
Why?
|
Protamines | 1 | 2020 | 112 | 0.170 |
Why?
|
Clinical Enzyme Tests | 1 | 2020 | 114 | 0.170 |
Why?
|
Subclavian Artery | 1 | 2020 | 133 | 0.170 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1813 | 0.170 |
Why?
|
Male | 41 | 2024 | 364781 | 0.160 |
Why?
|
Female | 43 | 2024 | 396943 | 0.160 |
Why?
|
Groin | 1 | 2019 | 107 | 0.160 |
Why?
|
Hospital Mortality | 7 | 2021 | 5371 | 0.160 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 414 | 0.150 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 385 | 0.150 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2019 | 463 | 0.150 |
Why?
|
Reoperation | 3 | 2024 | 4342 | 0.150 |
Why?
|
Platelet Count | 1 | 2020 | 786 | 0.140 |
Why?
|
Ischemic Attack, Transient | 2 | 2020 | 878 | 0.140 |
Why?
|
Angioplasty | 1 | 2019 | 357 | 0.130 |
Why?
|
Intermittent Claudication | 1 | 2018 | 305 | 0.130 |
Why?
|
Patient Discharge | 2 | 2020 | 3471 | 0.130 |
Why?
|
Humans | 50 | 2024 | 768451 | 0.130 |
Why?
|
Propensity Score | 2 | 2020 | 1971 | 0.120 |
Why?
|
Device Removal | 1 | 2020 | 641 | 0.120 |
Why?
|
Radiation Dosage | 2 | 2023 | 1973 | 0.110 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 458 | 0.110 |
Why?
|
Gastric Bypass | 3 | 2011 | 829 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1006 | 0.110 |
Why?
|
Emergencies | 1 | 2020 | 1222 | 0.110 |
Why?
|
Middle Aged | 21 | 2024 | 223418 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 849 | 0.110 |
Why?
|
United States | 15 | 2023 | 73121 | 0.110 |
Why?
|
Sigma Factor | 1 | 2013 | 177 | 0.100 |
Why?
|
Borrelia burgdorferi | 1 | 2013 | 183 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1226 | 0.090 |
Why?
|
RNA, Bacterial | 1 | 2013 | 393 | 0.090 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2011 | 93 | 0.090 |
Why?
|
Oxyntomodulin | 1 | 2010 | 8 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1519 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1214 | 0.090 |
Why?
|
Embolization, Therapeutic | 1 | 2020 | 1435 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1005 | 0.090 |
Why?
|
Ischemia | 1 | 2018 | 1900 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1162 | 0.080 |
Why?
|
Comprehension | 1 | 2015 | 641 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1950 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2257 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3253 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2485 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2018 | 12242 | 0.080 |
Why?
|
Caloric Restriction | 1 | 2011 | 300 | 0.080 |
Why?
|
Punctures | 2 | 2020 | 372 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1876 | 0.070 |
Why?
|
Odds Ratio | 1 | 2020 | 9687 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1299 | 0.070 |
Why?
|
Patient Selection | 4 | 2019 | 4266 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15460 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 591 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3111 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3308 | 0.060 |
Why?
|
Treatment Failure | 2 | 2024 | 2656 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3858 | 0.060 |
Why?
|
Obesity | 3 | 2011 | 13065 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6606 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3440 | 0.060 |
Why?
|
Canada | 2 | 2020 | 2143 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2489 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10358 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12875 | 0.050 |
Why?
|
Technology | 1 | 2023 | 296 | 0.050 |
Why?
|
Length of Stay | 3 | 2020 | 6521 | 0.050 |
Why?
|
Blood Glucose | 2 | 2018 | 6429 | 0.050 |
Why?
|
Heparin Antagonists | 1 | 2020 | 34 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4049 | 0.040 |
Why?
|
Constriction | 1 | 2019 | 168 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4285 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3861 | 0.040 |
Why?
|
Weight Loss | 1 | 2011 | 2710 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10845 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 298 | 0.040 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 43 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 148 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12813 | 0.040 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.040 |
Why?
|
Age Factors | 3 | 2019 | 18478 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10647 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13324 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2286 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1370 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2018 | 986 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 255 | 0.020 |
Why?
|
Carnitine | 1 | 2011 | 254 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2010 | 862 | 0.020 |
Why?
|
Ribosomes | 1 | 2013 | 500 | 0.020 |
Why?
|
Genes, Bacterial | 1 | 2013 | 1076 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7246 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2561 | 0.020 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2011 | 269 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 949 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2768 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8510 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2519 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1181 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3458 | 0.020 |
Why?
|
Animals | 1 | 2019 | 169418 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2010 | 487 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 797 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1640 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2096 | 0.020 |
Why?
|
Thrombosis | 1 | 2019 | 2956 | 0.010 |
Why?
|
Medicare | 1 | 2023 | 6881 | 0.010 |
Why?
|
Prospective Studies | 2 | 2023 | 54914 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8051 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9382 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3816 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41797 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5455 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12428 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21552 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6353 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11515 | 0.010 |
Why?
|
Adult | 4 | 2015 | 223542 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26351 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30243 | 0.000 |
Why?
|